PMID: 8588230Dec 1, 1995Paper

Mechanisms of action and overview of OKT3

Therapeutic Drug Monitoring
D J Norman

Abstract

OKT3 is a murine monoclonal antibody of the immunoglobulin IgG2a isotype. The target of OKT3, CD3, is a 17-20 kilodalton (kD) molecule that is part of a multimolecular complex found only on mature T cells and medullary thymocytes. This complex is uniquely situated next to the T-cell receptor for antigen. An interaction between T cells, OKT3, and monocytes causes T-cell activation (mitogenesis) in vitro. Because of the unique association between the antigen receptor and CD3, antibodies that react with CD3 block T-cell receptor function and vice versa. Thus, OKT3 blocks both the generation and function of cytotoxic T cells. After an initial dose of OKT3, T cells virtually disappear from the circulation within minutes to hours. During treatment with OKT3, T cells bearing the usual array of surface molecules (CD2, CD4, CD8) reappear in the peripheral blood circulation but these cells are devoid of the OKT3 target molecule, CD3. Within 48 hours of discontinuing OKT3, the normal array of surface molecules including CD3 is found again on all T cells. The selective removal of CD3 by internalization is thought to be the key mechanism of action of OKT3. Comodulation of the antigen receptor with CD3 explains the immunoblocking action of O...Continue Reading

Citations

Feb 21, 2013·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Dimitrios Karussis
Apr 23, 2004·Life Sciences·Antonella D'AmbrosioFrancesca Quintieri
Jun 19, 1998·The New England Journal of Medicine·M H Sayegh, L A Turka
Oct 27, 1998·AIDS Research and Human Retroviruses·C SmithG D Miralles
Nov 19, 2010·Bioanalysis·Bing KuangHuifen Faye Wang
May 19, 2010·Expert Review of Clinical Immunology·Peter J BugelskiEsther Bouman-Thio
Nov 25, 2011·Expert Opinion on Emerging Drugs·Lars P KihmChristian Morath
May 1, 2009·Expert Opinion on Drug Discovery·Maria Pia FuggettaMonica Rinaldi
May 12, 2009·Expert Opinion on Biological Therapy·Juliet EmamaulleeA M James Shapiro
Nov 4, 2000·Expert Opinion on Investigational Drugs·N Najafian, M H Sayegh
Jan 29, 2008·Toxicon : Official Journal of the International Society on Toxinology·Ales PremzlIgor Krizaj
Apr 25, 2007·Biochemical and Biophysical Research Communications·Bohua LiYajun Guo
Apr 21, 2007·The International Journal of Biochemistry & Cell Biology·Ming LvBeifen Shen
Apr 15, 2014·International Journal of Cancer. Journal International Du Cancer·Hossein PanjidehMartin Lipp
May 22, 2013·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Aaron MartinDaniel R Getts
Jul 17, 2012·Journal of Immunological Methods·S L MalcolmS Shaw
Mar 10, 2016·PloS One·Sabrina WeißmüllerZoe Waibler
Jun 2, 2016·Therapeutic Advances in Hematology·Jonathan E Benjamin, Anthony S Stein
Nov 12, 2020·Clinical & Translational Immunology·Alba Matas-CéspedesKourosh Saeb-Parsy
Mar 7, 2021·International Journal of Molecular Sciences·Filip CvetkovskiErik Berglund
Jun 3, 2021·International Journal of Molecular Sciences·Mariam ElshiatyPetros Christopoulos
Jul 21, 2021·Nanomedicine : Nanotechnology, Biology, and Medicine·Alexander S ZhovmerErdem D Tabdanov
Aug 28, 2021·International Journal of Molecular Sciences·Patricia GogeschMartina Anzaghe

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.